PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-6.90
Negative P/E while Healthcare median is -4.24. Seth Klarman would scrutinize path to profitability versus peers.
20.74
P/S exceeding 1.5x Healthcare median of 13.80. Jim Chanos would check for potential multiple compression risks.
1.76
P/B less than half the Healthcare median of 3.63. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-196.19
Negative FCF while Healthcare median P/FCF is -19.47. Seth Klarman would investigate cash flow improvement potential.
1154.27
Positive operating cash flow while Healthcare median is negative. Peter Lynch would examine operational advantage.
1.76
Fair value ratio less than half the Healthcare median of 3.63. Joel Greenblatt would investigate if this discount is justified.
-3.62%
Negative earnings while Healthcare median yield is -0.75%. Seth Klarman would investigate path to profitability.
-0.51%
Negative FCF while Healthcare median yield is -0.65%. Seth Klarman would investigate cash flow improvement potential.